Primary prevention: What can you tell your patient?

Surgical Oncology Clinics of North America

Volumn 9, Issue 4, 2000, Pages 655-660

  Friedlich, M S ^a   Stern, H S ^a  

^a CPC   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM; CELECOXIB; CYCLOOXYGENASE 2; FAT; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE; SUGAR;

CANCER CHEMOTHERAPY; CANCER GENETICS; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CANCER SURGERY; CARCINOGENESIS; CAUSE OF DEATH; CHEMOPROPHYLAXIS; CLINICAL TRIAL; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; DIET THERAPY; DIETARY INTAKE; DRUG MECHANISM; ENVIRONMENTAL FACTOR; HEALTH CARE COST; HUMAN; LIFESTYLE; PHYSICAL ACTIVITY; PRIMARY PREVENTION; PROTEIN EXPRESSION; REVIEW;

EID: 0033819631     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1055-3207(18)30100-5     Document Type: Review

References (38)

1. Inflammatory bowel disease
2. Epidemiology of cancer of the colon and rectum
3. Prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer
4. The adenoma-carcinoma sequence and prospects for the prevention of colorectal neoplasia
5. Colonic response to dietary fiber from carrot, cabbage, apple, bran and guar gum
6. Avoidable causes: Diet
7. Nonsteroidal anti-inflammatory drug use and sporadic colorectal adenomas
8. Ulcerative colitis and colorectal cancer: A population-based study
9. Induction of apoptotic cell death in human colorectal carcinoma cell lines by cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: Independence from COX- 2 protein expression
10. Primary prevention of colorectal cancer through fibre supplementation
11. Celecoxib, a COX-2-specific inhibitor: The clinical data
12. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: What can we expect
13. Solubility of calcium soaps of long chain fatty acids in simulated intestinal environment
14. Effect of high-fat and low fibre meals on the cell proliferation activity of colorectal mucosa
15. Effect of calcium supplementation on mucosal cell proliferation in high-risk patients for colon cancer
16. Colon cancer: Prevention and detection strategies
17. Colonic fermentation and markers of colorectal cancer risk
18. Chemopreventative activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis
19. Physical activity and the primary prevention of cancer
20. Chemoprevention of colorectal cancer
21. Role of cyclooxygenase-1 and -2 in health and disease
22. Prevention of gastrointestinal cancer: The potential role of NSA 1Ds in colorectal cancer
23. An update of FINPCC (Lynch syndrome)
24. Physical activity and colon cancer
25. The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis
26. A case-control study of colorectal adenomatous polyps and consumption of food containing partially hydrogenated oils
27. Insulin resistance syndrome and the risk of colorectal neoplasia
28. Effect of moderate exercise on bowel habit
29. Increased blood antioxidant systems of runners in responses to training load
30. Oral calcium suppresses increased rectal epithelia proliferation of persons at risk of colorectal cancer
31. Diet and the colonic environment: Measuring the response of human colonic bacteria to changes in the host's diet
32. Dietary fat and colon cancer: Modulation of cyclooxygenase- 2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis
33. Methylenetetrahydrofolate reductase, diet, and risk of colon cancer
34. Long term effects of dietary calcium on risk markers for colon cancer in patients with familial polyposis
35. Modification of bile acid spectrum by dietary fiber
36. Primary prevention of colorectal cancer through dietary modification